Compare Two Stocks
Valuation, growth, earnings reaction and guidance credibility, side by sideEWEdwards Lifesciences
FinDog View：Neutral
| Metric | AMGN | EW |
|---|
| Close | 376.35 | 89.28 |
| Market Cap | $203B | $51.5B |
| 1M | −10.26% | −1.68% |
| P/E (TTM) | 23.3 | 51.2 |
| Forward P/E | 16.9 | 29.8 |
| P/E 5-Yr Percentile | 27 | 98 |
| P/S | 5.4 | 7.9 |
| P/B | 17.4 | 4.9 |
| Dividend Yield | 3.21% | — |
| Latest Quarter Revenue | $10.1B | $1.7B |
| Revenue YoY | +9.5% | +13.6% |
| Gross Margin | 72.0% | 77.5% |
| Latest Quarter EPS | 4.37 | 0.42 |
| Avg Post-Earnings Move | ±5.2% | ±3.9% |
| EPS Beat Rate | — | — |
| Guidance Hit Rate | — | — |
| Shareholder Yield | 2.60% | 2.34% |
| 90-Day Net Insider Buying | −$4.1M | −$4.6M |
AMGN · Revenue, Last 8 Quarters ($B)
EW · Revenue, Last 8 Quarters ($B)
